[stent thrombosis : A won battle ? (data from the France PCI registry)].. Thrombose de stent : une bataille gagnée ? (Données du registre France PCI)

Archive ouverte

Rangé, Grégoire | Hakim, Radwan | Saint-Etienne, Christophe | Deballon, Ronan | Dechery, Thierry | Souteyrand, Geraud | Bar, Olivier | Albert, Franck | Canville, Alexandre | Gamet, Alexandre | Beygui, Farzin | Viallard, Louis | Bonnet, Pierre | Durand, Eric | Lesault, Pierre-François | Boiffard, Emmanuel | Koning, René | Benamer, Hakim | Commeau, Philippe | Cayla, Guillaume | Motreff, Pascal

Edité par CCSD ; Elsevier Masson -

International audience. Goal: The aim of the study is to assess the incidence, risk factors and prognosis of definite stent thrombosis (ST) at 1 year in the France PCI multicenter prospective registry.Patients and methods: Only patients who underwent coronary angioplasty with at least one stent implantation between 1st January 2014 and 31 December 2019 were included. The population was separated into 2 groups: the "ST" group with stent thrombosis and the "control" group without stent thrombosis.Results: 35,435 patients were included. 256 patients (0.72%) presented a ST at 1 year. The rate of ST decreased significantly in acute coronary syndrome (1.5% in 2014 vs. 0.73% in 2019; p = 0.05) but not in chronic coronary syndrome (0.46% in 2014 vs 0.40%; p = 0.98). The risk factors are young age (65.8 years vs 68.2; p = 0.002), clinical context (35.27% vs 16.68%; p = 0.0001), diabetes (35.2 % vs 26.4%; p = 0.002), renal failure (11.7% vs 8%; p = 0.009) and history of coronary angioplasty (28.63% vs 21.86%; p = 0.009) and peripheral arterial disease (14.5% vs 10.1%; p = 0.021), LV dysfunction (37% vs 27.5%; p = 0.003), mean length (39.6 mm vs 31, 7mm; p <0.0001) and the mean number of stents per procedure (1.9 vs 1.6; p <0.0001), a TIMI flow ≤1 pre procedure (21.5% vs 12.4%; p <0.0001) and an intrastent restenosis (11% vs 6%; p <0.0001). The 1-year mortality of the ST group was significantly higher than that of the control group (19.14% vs 5.82%; p <0.0001).Conclusion: Since 2014, the incidence of ST at 1 year has been decreasing but remains stuck at a floor level of 0.54% in 2019. The battle for ST seems to have been partly won and its risk factors well identified, but its mortality is still high.

Consulter en ligne

Suggestions

Du même auteur

Early survival after acute myocardial infarction with ST-segment elevation: What could be improved? Insights from France PCI French registry

Archive ouverte | Duband, Benjamin | CCSD

International audience. Early mortality post-ST-segment elevation myocardial infarction (STEMI) in France remains high. The multicentre France Percutaneous Coronary Intervention Registry includes every patient under...

Incidence, delays, and outcomes of STEMI during COVID‐19 outbreak: Analysis from the France PCI registry

Archive ouverte | Lesault, Pierre Francois | CCSD

International audience. ObjectivesThe aim of this study was to assess the impact of the coronavirus disease 2019 (COVID‐19) outbreak on incidence, delays, and outcomes of ST‐elevation myocardial infarction (STEMI) p...

Indirect Transfer to Catheterization Laboratory for ST Elevation Myocardial Infarction Is Associated With Mortality Independent of System Delays: Insights From the France-PCI Registry

Archive ouverte | Beygui, Farzin | CCSD

International audience. Background: First medical contact (FMC)-to-balloon time is associated with outcome of ST-elevation myocardial infarction (STEMI). We assessed the impact on mortality and the determinants of i...

Chargement des enrichissements...